Evidence map›Paper›PMID 33319213›Full record

ArticleJTCVS techniques2021

Controlled apneic tracheostomy in patients with coronavirus disease 2019 (COVID-19).

Kathleen D Weiss, Antonio Coppolino, Daniel C Wiener, Ciaran McNamee, Robert Riviello, Ju-Mei Ng, Michael T Jaklitsch, Margaret B Marshall, Matthew M Rochefort

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in JTCVS techniques, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 3 pooled it
1.1field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 3 syntheses or guidelines pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Systematic review and meta-analysis of tracheostomy outcomes in COVID-19 patients.The British journal of oral & maxillofacial surgery · 2021
    Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Kathleen D WeissDivision of Thoracic Surgery, Department of Surgery, Brigham and Women's Hospital, Boston, Mass.
Antonio CoppolinoDivision of Thoracic Surgery, Department of Surgery, Brigham and Women's Hospital, Boston, Mass.
Daniel C WienerDivision of Thoracic Surgery, Department of Surgery, Brigham and Women's Hospital, Boston, Mass.
Ciaran McNameeDivision of Thoracic Surgery, Department of Surgery, Brigham and Women's Hospital, Boston, Mass.
Robert RivielloDivision of Trauma, Burn, Surgical and Critical Care, Department of Surgery, Brigham and Women's Hospital, Boston, Mass.
Ju-Mei NgDepartment of Anesthesiology, Brigham and Women's Hospital, Boston, Mass.
Michael T JaklitschDivision of Thoracic Surgery, Department of Surgery, Brigham and Women's Hospital, Boston, Mass.
Margaret B MarshallDivision of Thoracic Surgery, Department of Surgery, Brigham and Women's Hospital, Boston, Mass.
Matthew M RochefortDivision of Thoracic Surgery, Department of Surgery, Brigham and Women's Hospital, Boston, Mass.
Brigham and Women's Hospital · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo develop a team-based institutional infrastructure for navigating management of a novel disease, to determine a safe and effective approach for performing tracheostomies in patients with COVID-19 respiratory failure, and to review outcomes of patients and health care personnel following implementation of this approach.

methodsAn interdisciplinary Task Force was constructed to develop innovative strategies for management of a novel disease. A single-institution, prospective, nonrandomized cohort study was then conducted on patients with coronavirus disease 2019 (COVID-19) respiratory failure who underwent tracheostomy using an induced bedside apneic technique at a tertiary care academic institution between April 27, 2020, and June 30, 2020.

resultsIn total, 28 patients underwent tracheostomy with induced apnea. The median lowest procedural oxygen saturation was 95%. The median number of ventilated days following tracheostomy was 11. There were 3 mortalities (11%) due to sepsis and multiorgan failure; of 25 surviving patients, 100% were successfully discharged from the hospital and 76% are decannulated, with a median time of 26 days from tracheostomy to decannulation (range 12-57). There was no symptomatic disease transmission to health care personnel on the COVID-19 Tracheostomy Team.

conclusionsPatients with respiratory failure from COVID-19 disease may benefit from tracheostomy. This can be completed effectively and safely without viral transmission to health care personnel. Performing tracheostomies earlier in the course of disease may expedite patient recovery and improve intensive care unit resource use. The creation of a collaborative Task Force is an effective strategic approach for management of novel disease.

Indexed as

coronavirusCOVID-19COVID-19, coronavirus disease 2019ECMO, extracorporeal membrane oxygenationICU, intensive care unitOR, operating roompandemicPPE, personal protective equipmentRT, respiratory therapistSARS-CoV-2SARS-CoV-2, severe acute respiratory distress syndrome coronavirus 2tracheostomy

Identifiers

PMID33319213
PMCPMC7720733
OpenAlexW3111129851

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.